Mr. Robert Rubin is an experienced professional in corporate development and mergers and acquisitions (M&A). He served in Sterling Drug, Inc. as Director of Corporate Development. Pior, Mr. Rubin was Director of Corporate Development at Revlon, Inc. where he directed the company’s diversification from its core beauty
business into the healthcare business. Additionally, he served in Citibank, where as a Vice President he managed all phases of a $500 million loan portfolio.
Since transitioning to the B2G sector, Mr. Rubin is a senior leader in M&A and other investment banking services for the technology arena, with a focus on companies involved in government contracting.